Literature DB >> 20518791

Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.

Eisuke Kaneki1, Hiroaki Kobayashi, Toshio Hirakawa, Takao Matsuda, Hidenori Kato, Norio Wake.   

Abstract

In the present study, we evaluated the incidence of postmolar gestational trophoblastic disease (GTD) in molar pregnancy. We also validated the macroscopic diagnosis based on the Japan Society of Obstetrics and Gynecology (JSOG) classification. A total of 297 samples of hydropic villi were classified according to DNA polymorphisms as androgenetic moles, dispermic triploids, or biparental diploids (hydropic abortion), clinically corresponding to complete hydatidiform mole (CHM), partial hydatidiform mole (PHM), and hydropic abortion, respectively. These samples were also classified morphologically based on the JSOG classification. A follow-up study was performed to investigate the incidence of postmolar GTD. A subset of 267 samples eligible for testing were analyzed and diagnosed as androgenetic moles (232 cases), dispermic triploids (20 cases), and biparental diploids (15 cases). Most of the macroscopically diagnosed CHM cases were genetically androgenetic in origin. The PHM cases consisted of 30 androgenetic moles and 12 dispermic triploids. We reviewed the outcomes of 200 patients (178 cases of androgenetic mole, 13 cases of dispermic triploids, and nine cases of biparental diploids). Twenty-eight cases (16%) of androgenetic moles developed postmolar GTD. None of the patients with dispermic triploids developed postmolar GTD. Among the 28 patients who developed postmolar GTD, the shortest diameter of the largest hydropic villi was significantly longer than that of patients not developing postmolar GTD. None of the patients with androgenetic moles who had hydropic villi <2 mm in their shortest diameter developed postmolar GTD. For the patients with dispermic triploids, the risk of postmolar GTD is extremely low. The risk of postmolar GTD is also low in patients with androgenetic moles with small hydropic villi. The JSOG classification based on the morphology of hydropic villi is reliable for the diagnosis of CHM, but inaccurate for the diagnosis of PHM or "microscopic" moles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518791     DOI: 10.1111/j.1349-7006.2010.01602.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

1.  Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.

Authors:  Yassemine Khawajkie; Nawel Mechtouf; Ngoc Minh Phuong Nguyen; Kurosh Rahimi; Magali Breguet; Jocelyne Arseneau; Brigitte M Ronnett; Lori Hoffner; Felicia Lazure; Marjolaine Arnaud; Fabrice Peers; Liane Tan; Basam Abu Rafea; Monica Aguinaga; Neil S Horowitz; Asangla Ao; Seang Lin Tan; Richard Brown; William Buckett; Urvashi Surti; Karine Hovanes; Trilochan Sahoo; Philippe Sauthier; Rima Slim
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

2.  Establishment and characterization of cell lines derived from complete hydatidiform mole.

Authors:  Eiko Yamamoto; Kaoru Niimi; Tohru Kiyono; Toshimichi Yamamoto; Kimihiro Nishino; Kenichi Nakamura; Tomomi Kotani; Hiroaki Kajiyama; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Int J Mol Med       Date:  2017-07-14       Impact factor: 4.101

3.  The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.

Authors:  Eiko Yamamoto; Tien Dat Trinh; Yoko Sekiya; Koji Tamakoshi; Xuan Phuoc Nguyen; Kimihiro Nishino; Kaoru Niimi; Tomomi Kotani; Hiroaki Kajiyama; Kiyosumi Shibata; Quang Thanh Le; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

4.  MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.

Authors:  Zhenzhen Guo; Qiannan Sun; Yangyou Liao; Chao Liu; Wenjie Zhao; Xiaoxue Li; Huan Liu; Ming Dong; Yuhong Shang; Linlin Sui; Ying Kong
Journal:  J Cell Mol Med       Date:  2020-06-23       Impact factor: 5.310

5.  Genome-wide single nucleotide polymorphism array analysis unveils the origin of heterozygous androgenetic complete moles.

Authors:  Hirokazu Usui; Kazuhiko Nakabayashi; Kayoko Maehara; Kenichiro Hata; Makio Shozu
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

6.  Triploidy--Observations in 154 Diandric Cases.

Authors:  Nanna Brink Scholz; Lars Bolund; Mette Nyegaard; Louise Faaborg; Mette Warming Jørgensen; Helle Lund; Isa Niemann; Lone Sunde
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

7.  PADI6 Regulates Trophoblast Cell Migration-Invasion Through the Hippo/YAP1 Pathway in Hydatidiform Moles.

Authors:  Bo Huang; Yating Zhao; Lin Zhou; Tingyu Gong; Jiawen Feng; Peilin Han; Jianhua Qian
Journal:  J Inflamm Res       Date:  2021-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.